5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.99▲ | 0.99▲ | 0.99▲ | 0.97▲ | 1.02▼ |
MA10 | 0.99▲ | 0.98▲ | 0.98▲ | 1.01▼ | 0.95▲ |
MA20 | 0.99▲ | 0.98▲ | 0.98▲ | 1.02▼ | 0.73▲ |
MA50 | 0.98▲ | 0.98▲ | 0.99▲ | 0.93▲ | 0.71▲ |
MA100 | 0.98▲ | 1.00▼ | 1.04▼ | 0.70▲ | 0.90▲ |
MA200 | 0.98▲ | 1.03▼ | 1.02▼ | 0.68▲ | 1.20▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.002▲ | 0.003▲ | -0.020▼ | 0.041▲ |
RSI | 79.170▲ | 61.007▲ | 54.611▲ | 49.433▼ | 60.675▲ |
STOCH | 88.290▲ | 89.749▲ | 77.764 | 10.233▼ | 73.402 |
WILL %R | -25.592 | -11.111▲ | -13.427▲ | -82.143▼ | -29.487 |
CCI | 387.381▲ | 100.967▲ | 82.290 | -66.667 | 51.862 |
Monday, August 04, 2025 05:15 AM
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious neurological and ...
|
Monday, July 14, 2025 03:56 PM
1 D 5 D 1 M 3 M YTD 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Health Care/Life Sciences Compare to Add Open 1.03 Prior Close 1.03 (07/11/25) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 0.96 | 1.00 | 0.95 | 0.98 | 657,600 |
07/08/25 | 1.00 | 1.02 | 0.95 | 0.95 | 1,008,900 |
06/08/25 | 0.97 | 1.02 | 0.96 | 0.99 | 1,059,700 |
05/08/25 | 0.97 | 1.00 | 0.95 | 0.96 | 788,900 |
04/08/25 | 1.00 | 1.02 | 0.95 | 0.97 | 988,000 |
01/08/25 | 1.01 | 1.04 | 0.96 | 0.99 | 2,004,900 |
31/07/25 | 1.06 | 1.09 | 1.01 | 1.02 | 820,400 |
30/07/25 | 1.06 | 1.08 | 1.00 | 1.03 | 1,579,400 |
29/07/25 | 1.18 | 1.18 | 1.07 | 1.07 | 1,860,300 |
28/07/25 | 1.14 | 1.21 | 1.13 | 1.17 | 1,819,061 |
|
|
||||
|
|
||||
|
|